Clinical trial

Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)

NCT00406302

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-01-01

PhasePHASE2

Study timeline

Study start (unknown)2007-01-01Date precision: month

Registry last updated2014-04-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-small-cell Lungunresolved

Interventions

DocetaxelDRUG · verified · RxNorm: docetaxel

oxaliplatinDRUG · verified · RxNorm: oxaliplatin

cetuximabDRUG · verified · RxNorm: cetuximab

surgeryPROCEDURE

Sponsors & collaborators

Wolfgang Hilbelead sponsor

Merck Sharp & Dohme LLCcollaborator

Sanoficollaborator

TAKO - Tiroler Arbeitskreis Onkologiecollaborator

Mapped research locations

LinzAustria2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00406302 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.